ArticlePolymers2026
Multifunctional 3D-Printed Polylactic Acid/Hydroxyapatite Systems for Cranial Applications: Functionalization and Local Anti-Inflammatory Drug Delivery.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Traumatic Brain Injuries (TBIs) frequently require cranioplasty procedures to restore skull integrity and protect underlying brain. Conventional cranial implants are often limited by inadequate osteointegration, risk of inflammation, infection, or the need for secondary surgical interventions. In this study, a multifunctional strategy for cranial reconstruction is proposed, combining additive manufacturing, bioactive surface functionalization, and local drug delivery. Porous polylactic acid (PLA) scaffolds were fabricated by Fused Deposition Modelling (FDM) to obtain lightweight structures with controlled porosity. The scaffolds were subsequently functionalized with hydroxyapatite coatings, deposited through sol-gel, to provide osteointegrative properties. To locally modulate post-implant inflammatory responses, a drug delivery system based on polycaprolactone (PCL) microparticles loaded with dexamethasone was developed and entrapped within hydroxyapatite-coated PLA structures. The produced systems were extensively characterized in terms of morphology, mechanical and thermal behavior, structural properties, biological response, and drug release behavior. Results demonstrated that the 3D-printed scaffolds exhibited homogeneous hydroxyapatite coatings, whose continuity and retention were enhanced by NaOH surface pre-treatment. Biological assays demonstrated that HAp coating significantly improved cell viability and osteogenic differentiation, confirming the osteoconductive potential of the scaffolds for craniofacial bone regeneration applications. Dexamethasone-loaded PCL microparticles were successfully integrated into the coated scaffolds, exhibiting controlled drug release, absence of cytotoxicity, and homogeneous distribution within the porous architecture, thereby demonstrating the feasibility of a multifunctional platform combining bone-regenerative and therapeutic delivery functionalities. Overall, the proposed multifunctional scaffolds represent a promising, low-cost and customizable approach for advanced cranioplasty applications, integrating structural support, osteointegration and local anti-inflammatory therapy within a single system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.